Gadolinium Resources

S&C Main Content Sections
>> Gadolinium
Nephrogenic Systemic Fibrosis (NSF)
Nephrogenic Fibrosing Dermopathy (NFD)
Just Added - Over 30 New Gadolinium NSF/NFD Articles
Click Here: MRI Contrast Agent Articles
Gadolinium Based Contrast Agents have been linked to a serious, life-threatening skin disorder called Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermopathy (NFD).
If you or somebody you know has developed a skin irritation or a problem with limb mobility after having received an MRI or MRA, you need to speak with your doctor immediately. These symptoms may be associated with an underlying kidney or liver problem and the development of NSF or NFD.
In addition, you may be entitled to compensation if you have developed NSF or NFD after having received an injection of gadolinium-based contrast agents during an MRI or MRA. Please click the following link to contact us for a free confidential case evaluation.
Just Added - Over 30 New Gadolinium NSF/NFD Articles
Click Here: MRI Contrast Agent Articles
UPDATE: Read the May 23, 2007 FDA press release, "FDA Requests Boxed Warning for Contrast Agents Used to Improve MRI Images."
The U.S. Food and Drug Administration (FDA) has requested the manufacturers of gadolinium-based contrast agents to add a new boxed warning on the product labeling because of new reports linking the agents to a life-threatening skin disorder.
The requested boxed warning would state:
“Patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as Nephrogenic Systemic Fibrosis (NSF). In addition, it would state that patients just before or just after liver transplantation, or those with chronic liver disease, are also at risk for developing NSF if they are experiencing kidney insufficiency of any severity.”
Gadolinium-based contrast agents are often used to improve the visibility of internal structures when patients undergo an MRI or MRA. These gadolinium based contrast agents are injected into veins of the patient so that the physician can view a clear and detailed picture of a patient’s internal organs, tissues, bones and/or vessels.
Five gadolinium-based contrast agents have been approved for use in the United States:
Magnetic Resonance Imaging (MRIs) and Magnetic Resonance Angiography (MRAs) are typically ordered by physicians in order to detect abnormalities such as tumors, clots, bleeds, and related medical problems.
Nephrogenic Systemic Fibrosis (NSF), also known as Nephrogenic Fibrosing Dermopathy (NFD), is a skin condition that is often described as a swelling and tightening of the skin, usually limited to the extremities. The condition may develop over a short period of days or could take weeks to fully develop. Severely affected patients may be unable to walk, or fully extend the joints of their arms, hands, legs, and feet. Complaints of muscle weakness are common.
The Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Gadolinium lawsuits. We are handling individual litigation nationwide and currently accepting new Gadolinium side effect cases in all 50 states.
Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.
Free Confidential Case Evaluation
Toll Free 24 hrs/day (866) 588-0600
Secure 128-bit SSL Encrypted Email Communication - Click Here.
Secure 1024-bit SSL Encrypted Live Chat Communication - Click Here.
= Required Field
| Luna Innovations Rolls Out MRI Contrast Agent - TradingMarkets.com nanoWorks said the class of molecules provides a platform upon which Luna plans to build a portfolio of nanomedicines aimed at disease targeting and diagnostic imaging. MRI is a non-invasive diagnostic procedure that enables physicians to visualize ... MRI Technique Could Predict Heart Attack Risk - HealthCentral.com Copyright © 2007 ScoutNews, LLC. All rights reserved. WEDNESDAY, March 28 (HealthDay News) -- An imaging technique based on the natural properties of "good" HDL cholesterol could someday help doctors spot patients at high risk of heart attack or ... How Is Colorectal Cancer Diagnosed? - American Cancer Society While colorectal cancer is often found after symptoms appear, most people with early colon or rectal cancer have no symptoms of the disease. Symptoms usually appear only with more advanced disease. This is why getting the recommended screening tests ... World's first MOSFETs with epitaxial Gd2O3 - PhysOrg Researchers at AMICA and Technical University of Darmstadt have successfully fabricated the world's first MOSFETs on ultra-thin-body silicon-on-insulator (SOI) material and bulk silicon with a crystalline gadolinium oxide (Gd 2 O 3 ) gate dielectric ... Click here to view the list of recent Press Releases from LegalView - PR.com LegalView recently updated its Heparin information portal on the latest news regarding the contaminated batch of Heparin, which may have sickened hundreds and caused the death of up to 90 individuals. U.S. officials have sourced the contamination to ... Transient Ischemic Attack (TIA) - Belief.Net Pronounced: trans-EE-ent isk-EE-mik uh-tak The doctor will ask about your symptoms and medial history, and perform a physical exam, paying particular attention to your blood pressure and nervous system. A primary goal will be to determine your stroke ... Pharmacyclics Demonstrates Potential Inhibition In Multiple Types Of ... - eMaxHealth.com Pharmacyclics presented preclinical results demonstrating the anti-tumor activity of PCI-27483, the company's small-molecule Factor VIIa inhibitor. The data were presented during the Annual Meeting of the American Association for Cancer Research ... Researchers Mimic Bacteria To Produce Magnetic Nanoparticles - Science Daily ScienceDaily (Apr. 15, 2008) ? When it comes to designing something, it?s hard to find a better source of inspiration than Mother Nature. Using that principle, a diverse, interdisciplinary group of researchers at the U.S. Department of Energy?s ... Luna Innovations Plans Preclinical Studies and Collaboration with ... - Phramalive.com ROANOKE, Va.--(BUSINESS WIRE)--Apr 9, 2008 - Luna Innovations Incorporated (NASDAQ:LUNA) announces the National Cancer Institute has selected Luna's magnetic resonance imaging (MRI) contrast agent candidate for preclinical characterization by the ... LegalView Reports Information About Asbestos Removal Falsified by ... - PR.com LegalView recently updated its mesothelioma blog with information about a school official who had falsified records and reports regarding asbestos removal in local New York schools. Denver, CO, March 05, 2008 --( PR.com )-- LegalView.com recently ... |
5/23/07 - FDA Press Release
2/07/07 - Study Links Gadolinium treatment to NSF
1/25/07 - MRI Contrast Agent Linked to Rare Disease
1/15/07 - Dialysis to Prevent NSF After Gadolinium Treatment